June 13, 2026 12:05 PM ET
Agios Pharmaceuticals Touts Mitapivat Gains Despite Sickle Cell Pain Miss
MarketBeat
Agios Pharmaceuticals (NASDAQ:AGIO) used an investor webcast tied to the 2026 European Hematology Association Congress in Stockholm to highlight new clinical data for mitapivat across thalassemia and sickle cell disease, while outlining a broader rare disease strategy that now includes multiple hema
NASDAQ:AGIO